Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Net Asset Quality Index
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a Net Asset Quality Index of 84.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs2.99 Billion minus total liabilities of Rs461.88 Million yields net assets of Rs2.53 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Jagsonpal Pharmaceuticals Limited to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jagsonpal Pharmaceuticals Limited Net Asset Quality Index Over Time (2006–2025)
This chart shows how Jagsonpal Pharmaceuticals Limited's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the index stands at 84.6%, representing net assets of Rs2.53 Billion against total assets of Rs2.99 Billion INR. See JAGSNPHARM net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Jagsonpal Pharmaceuticals Limited (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Jagsonpal Pharmaceuticals Limited from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Jagsonpal Pharmaceuticals Limited market cap and net worth.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.2% | Rs2.40 Billion | Rs2.78 Billion | Rs383.10 Million | ▼ -0.1 pp |
| 2024 | 86.3% | Rs1.87 Billion | Rs2.17 Billion | Rs296.76 Million | ▲ +4.8 pp |
| 2023 | 81.5% | Rs1.59 Billion | Rs1.95 Billion | Rs360.56 Million | ▲ +3.8 pp |
| 2022 | 77.7% | Rs1.31 Billion | Rs1.68 Billion | Rs375.99 Million | ▲ +3.4 pp |
| 2021 | 74.3% | Rs1.22 Billion | Rs1.64 Billion | Rs422.73 Million | ▼ -1.3 pp |
| 2020 | 75.6% | Rs1.11 Billion | Rs1.47 Billion | Rs359.21 Million | ▼ -1.4 pp |
| 2019 | 76.9% | Rs1.04 Billion | Rs1.36 Billion | Rs313.11 Million | ▲ +1.4 pp |
| 2018 | 75.5% | Rs980.47 Million | Rs1.30 Billion | Rs317.68 Million | ▼ -1.5 pp |
| 2017 | 77.1% | Rs1.10 Billion | Rs1.43 Billion | Rs326.97 Million | ▲ +15.3 pp |
| 2016 | 61.8% | Rs983.64 Million | Rs1.59 Billion | Rs609.17 Million | ▼ -0.1 pp |
| 2015 | 61.9% | Rs954.26 Million | Rs1.54 Billion | Rs587.94 Million | ▼ -1.2 pp |
| 2014 | 63.1% | Rs985.89 Million | Rs1.56 Billion | Rs576.68 Million | ▼ -1.2 pp |
| 2013 | 64.3% | Rs983.71 Million | Rs1.53 Billion | Rs546.30 Million | ▲ +1.2 pp |
| 2012 | 63.1% | Rs984.69 Million | Rs1.56 Billion | Rs576.30 Million | ▼ -4.9 pp |
| 2011 | 68.0% | Rs929.14 Million | Rs1.37 Billion | Rs438.04 Million | ▼ -3.1 pp |
| 2010 | 71.1% | Rs875.70 Million | Rs1.23 Billion | Rs356.69 Million | ▲ +5.8 pp |
| 2009 | 65.3% | Rs801.68 Million | Rs1.23 Billion | Rs426.09 Million | ▲ +7.7 pp |
| 2008 | 57.6% | Rs750.34 Million | Rs1.30 Billion | Rs552.21 Million | ▲ +8.4 pp |
| 2007 | 49.2% | Rs724.98 Million | Rs1.47 Billion | Rs749.83 Million | ▼ -0.5 pp |
| 2006 | 49.6% | Rs702.35 Million | Rs1.42 Billion | Rs713.18 Million | — |